Literature DB >> 24255772

Clinical utility of the ventricular septal defect diameter to aorta root diameter ratio to predict early childhood developmental defects or lung infections in patients with perimembranous ventricular septal defect.

Jin-Xiang Liu1, Jing-Hua Wang, Si-Rui Yang, Min Liu, Yang Xu, Jing-Hui Sun, Chao-Ying Yan.   

Abstract

BACKGROUND: Ventricular septal defect (VSD) is the most frequent type of congenital heart disease. Conventional methods to evaluate VSD size and severity are both invasive and cumbersome to perform. We investigated whether the ratio between the diameter of the defect and the aortic root diameter (DVSD/DAR) would accurately reflect the degree of shunted blood and the severity of VSD in children with perimembranous VSD.
METHODS: We recruited 987 children with perimembranous VSD (pmVSD) and used color Doppler echocardiography to calculate DVSD/DAR. 987 healthy children were recruited as control group. The pmVSD group was further stratified into four groups according to age (1 to 4 y) and again into four groups according to the DVSD/DAR ratio: children whose DVSD/DAR was 1/5 to <1/4, 1/4 to <1/3, 1/3 to 1/5, or 1/2 to <2/3 were assigned to groups A, B, C, and D, respectively. Height, weight, infection scores and systemic-pulmonary circulation ratio (QP/QS ratio) were compared among groups A, B, C and D. Then the relationship between the DVSD/DAR ratio and height, weight, QP/QS ratio, infection score were analysed by linear regression analysis.
RESULTS: Compared to age-matched children without VSD (the controls), the mean height and weight of children in the pmVSD group were lower, and heights and weights were negatively correlated with the DVSD/DAR ratio. This ratio was significantly reduced in groups C and D compared to control group (both P<0.05). Infection scores of groups A and B were significantly higher only in the one-year-old subgroup, but were significantly higher in groups C and D for all ages compared to the control group (both P<0.05). QP/QS ratio of group C and D were higher than group A and group B (all P<0.05). Moreover, QP/QS ratio of group D for all ages were more than 2. In addition, linear regression analysis revealed that the DVSD/DAR ratio negatively correlated with height and weight and positively correlated with the QP/QS ratio and infection score.
CONCLUSIONS: Our results suggest that the DVSD/DAR ratio accurately reflects the growth and pulmonary infection rates in children with pmVSD. This ratio, therefore, may be a useful additional reference index to predict the consequences of pmVSD.

Entities:  

Keywords:  Perimembranous ventricular septal defect (VSD); growth; pulmonary infection; ratio between defect diameter and the aortic root diameter (DVSD/DAR)

Year:  2013        PMID: 24255772      PMCID: PMC3815726          DOI: 10.3978/j.issn.2072-1439.2013.09.05

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  17 in total

1.  Growth after ventricular septal defect repair: does defect size matter? A 10-year experience.

Authors:  Paulo Henrique Manso; F Carmona; A D N Jácomo; H Bettiol; M A Barbieri; A P C P Carlotti
Journal:  Acta Paediatr       Date:  2010-09       Impact factor: 2.299

2.  Echocardiographic automated cardiac output measurement of pulmonary output and quantification of intracardiac shunt.

Authors:  Nicolas Mansencal; Fabrice Martin; Jean-Christian Farcot; Franck Digne; Thierry Joseph; Rémy Pilliére; Alban Redheuil; Pascal Lacombe; Olivier Dubourg
Journal:  Int J Cardiol       Date:  2005-09-15       Impact factor: 4.164

3.  Ventricular septal defect with secondary left ventricular-to-right atrial shunt is associated with a higher risk for infective endocarditis and a lower late chance of closure.

Authors:  Mei-Hwan Wu; Jou-Kou Wang; Ming-Tai Lin; En-Ting Wu; Frank Leigh Lu; Sheunn-Nan Chiu; Hung-Chi Lue
Journal:  Pediatrics       Date:  2006-01-17       Impact factor: 7.124

4.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

5.  Noninvasive assessment of left-to-right shunting in ventricular septal defects by the proximal isovelocity surface area method on Doppler colour flow mapping.

Authors:  Mustafa Kosecik; Gul Sagin-Saylam; Nurettin Unal; Mustafa Kir; Sebnem Paytoncu
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

6.  Closure of muscular ventricular septal defects guided by en face reconstruction and pictorial representation.

Authors:  Kothandam Sivakumar; Sivadasan Radha Anil; Suresh G Rao; Krishnanaik Shivaprakash; Raman Krishna Kumar
Journal:  Ann Thorac Surg       Date:  2003-07       Impact factor: 4.330

7.  Management of infants with large, unrepaired ventricular septal defects and respiratory infection requiring mechanical ventilation.

Authors:  Mahesh Bhatt; Stephen J Roth; R Krishna Kumar; Kimberlee Gauvreau; Suresh G Nair; Suresh Chengode; Krishnanaik Shivaprakasha; Suresh G Rao
Journal:  J Thorac Cardiovasc Surg       Date:  2004-05       Impact factor: 5.209

8.  Long-term follow-up and quality of life after closure of ventricular septal defect in adults.

Authors:  Goris Bol Raap; Folkert J Meijboom; A Pieter Kappetein; Tjebbe W Galema; Singh-Chien Yap; Ad J J C Bogers
Journal:  Eur J Cardiothorac Surg       Date:  2007-06-12       Impact factor: 4.191

9.  Morphological, haemodynamic, and clinical variables as predictors for management of isolated ventricular septal defect.

Authors:  F van den Heuvel; T Timmers; J Hess
Journal:  Br Heart J       Date:  1995-01

10.  Quantitation of echocardiographic predictors of outcome in infants with isolated ventricular septal defect.

Authors:  G S Shirali; E O Smith; T Geva
Journal:  Am Heart J       Date:  1995-12       Impact factor: 4.749

View more
  1 in total

1.  Factors influencing the spontaneous closure of ventricular septal defect in infants.

Authors:  Yang Xu; Jinxiang Liu; Jinghua Wang; Min Liu; Hui Xu; Sirui Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.